Literature DB >> 28737774

Outcomes of salvage autologous stem cell transplantation for multiple myeloma with cytopenias and exposure to novel agents.

D Tremblay1, G Lancman1, E Moshier1, N Bar2, S Jagannath1, A Chari1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28737774     DOI： 10.1038/bmt.2017.160

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  Factors influencing the outcome of a second autologous stem cell transplant (ASCT) in relapsed multiple myeloma: a study from the British Society of Blood and Marrow Transplantation Registry.

Authors:  Gordon Cook; Effie Liakopoulou; Rachel Pearce; Jim Cavet; Gareth J Morgan; Keiren Kirkland; Julia Lee; Faith E Davies; Rachel Hall; Amin Rahemtulla; Nigel Russell; David I Marks
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-23       Impact factor: 5.742

2.  Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients.

Authors:  Leopold Sellner; Christiane Heiss; Axel Benner; Marc S Raab; Jens Hillengass; Dirk Hose; Nicola Lehners; Gerlinde Egerer; Anthony D Ho; Hartmut Goldschmidt; Kai Neben
Journal:  Cancer       Date:  2013-04-10       Impact factor: 6.860

3.  Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantation.

Authors:  Roland Fenk; Vanessa Liese; Florian Neubauer; Ingmar Bruns; Mustafa Kondakci; Sebastian Balleisen; Christian Saure; Thomas Schröder; Rainer Haas; Guido Kobbe
Journal:  Leuk Lymphoma       Date:  2011-06-10

4.  Salvage second hematopoietic cell transplantation in myeloma.

Authors:  Laura C Michaelis; Ayman Saad; Xiaobo Zhong; Jennifer Le-Rademacher; Cesar O Freytes; David I Marks; Hillard M Lazarus; Jennifer M Bird; Leona Holmberg; Rammurti T Kamble; Shaji Kumar; Michael Lill; Kenneth R Meehan; Wael Saber; Jeffrey Schriber; Jason Tay; Dan T Vogl; Baldeep Wirk; Bipin N Savani; Robert P Gale; David H Vesole; Gary J Schiller; Muneer Abidi; Kenneth C Anderson; Taiga Nishihori; Matt E Kalaycio; Julie M Vose; Jan S Moreb; William Drobyski; Reinhold Munker; Vivek Roy; Armin Ghobadi; H Kent Holland; Rajneesh Nath; L Bik To; Angelo Maiolino; Adetola A Kassim; Sergio A Giralt; Heather Landau; Harry C Schouten; Richard T Maziarz; Joseph Mikhael; Tamila Kindwall-Keller; Patrick J Stiff; John Gibson; Sagar Lonial; Amrita Krishnan; Angela Dispenzieri; Parameswaran Hari
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-05       Impact factor: 5.742

5.  Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT.

Authors:  M Grövdal; H Nahi; G Gahrton; J Liwing; A Waage; N Abildgaard; P T Pedersen; J Hammerstrøm; A Laaksonen; P Bazia; V Terava; H Ollikainen; R Silvennoinen; M Putkonen; P Anttila; K Porkka; K Remes
Journal:  Bone Marrow Transplant       Date:  2015-04-13       Impact factor: 5.483

6.  Second autologous stem cell transplant: an effective therapy for relapsed multiple myeloma.

Authors:  Kamal Kant Singh Abbi; Junting Zheng; Sean M Devlin; Sergio Giralt; Heather Landau
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

7.  Durable remission with salvage second autotransplants in patients with multiple myeloma.

Authors:  Nina Shah; Fraz Ahmed; Qaiser Bashir; Sofia Qureshi; Yvonne Dinh; Gabriela Rondon; Sijin Wen; Peter Thall; Hassan Khan; Sergio Giralt; Richard Champlin; Muzaffar H Qazilbash
Journal:  Cancer       Date:  2011-11-15       Impact factor: 6.860

8.  Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study.

Authors:  S K Kumar; J H Lee; J J Lahuerta; G Morgan; P G Richardson; J Crowley; J Haessler; J Feather; A Hoering; P Moreau; X LeLeu; C Hulin; S K Klein; P Sonneveld; D Siegel; J Bladé; H Goldschmidt; S Jagannath; J S Miguel; R Orlowski; A Palumbo; O Sezer; S V Rajkumar; B G M Durie
Journal:  Leukemia       Date:  2011-07-29       Impact factor: 11.528

9.  Salvage autologous stem cell transplantation for multiple myeloma relapsing or progressing after up-front autologous transplantation.

Authors:  Holger W Auner; Richard Szydlo; Alero Rone; Aristeidis Chaidos; Chrissy Giles; Ed Kanfer; Donald H Macdonald; David Marin; Dragana Milojkovic; Jiri Pavlu; Jane F Apperley; Amin Rahemtulla
Journal:  Leuk Lymphoma       Date:  2013-03-04

10.  Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT.

Authors:  H-Y Yhim; K Kim; J S Kim; H J Kang; J-A Kim; C-K Min; S H Bae; E Park; D-H Yang; C Suh; M K Kim; Y-C Mun; H S Eom; H J Shin; H-J Yoon; J H Kwon; J H Lee; Y S Kim; S-S Yoon; J-Y Kwak
Journal:  Bone Marrow Transplant       Date:  2012-09-03       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.